Summary: Jump Financial LLC decreased its holdings in shares of Honeywell International Inc. (NASDAQ:HON) by 87.5% in the fourth quarter, reducing their stock ownership to 3,788 shares valued at $794,000. Honeywell International's stock price decreased by 0.3% and the company announced a quarterly dividend. Wall Street analysts have forecasted growth for Honeywell International. Insiders, including Director Darius Adamczyk and CFO Gregory P. Lewis, have been actively selling shares of the company.
Full articleSummary: Ford plans to refresh the Ford Equator, a massive SUV, with a new plug-in hybrid powertrain and fresh design elements. It will be manufactured in China as part of the JMC-Ford joint venture.
Full articleSummary: Nike reveals new releases for the upcoming fall season, including the women’s exclusive 'Sesame/Ironstone' edition of the Dunk Low.
Full articleSummary: Google mistakenly deleted Australia's UniSuper pension fund account worth $125 billion, affecting over half a million members. The incident, caused by a misconfiguration on Google Cloud, highlighted vulnerabilities in cloud computing services.
Full articleSummary: Tesla is strategically focusing on becoming a low-cost producer and launching new affordable car models to reach its ambitious goal of selling 20 million electric cars by 2030. The company's recent financial performance showed a decline in growth rates and revenue, emphasizing the challenges ahead in achieving its targets.
Full articleSummary: Nvidia is diversifying beyond its GPU business into AI-related products and services, highlighting software as a potential growth driver. The company's AI Enterprise service, described as an operating system for AI, has reached a $1 billion run rate and is expected to see increased demand in the future.
Full articleSummary: Apple launches aggressive discounting campaign on its official Tmall site in China, offering discounts of up to 2,300 yuan on select iPhone models to compete with local rivals like Huawei. The discounting aims to defend Apple's position in the high-end smartphone market.
Full articleSummary: Lockheed Martin wins a $756 million contract to provide LRHW battery equipment and support to the US Army. This system is designed to launch hypersonic missiles and includes a battery operations center and launchers. The LRHW project is part of the US Army's efforts to advance future long-range fires.
Full articleSummary: Ford CEO is open to exploring new variants of the Mustang, including a possible 4-door iteration with a V8 engine and manual gearbox. However, he rules out the idea of making an all-electric Mustang.
Full articleSummary: Microsoft is betting big on AI, focusing on AI PCs powered by Intel's Meteor Lake processors to drive Windows sales. The company's investment in AI and Windows revenue increase indicate a promising future.
Full articleSummary: Wall Street is optimistic about Nvidia's upcoming quarterly report, with expectations of strong revenue and net income growth. Analysts foresee a 242% jump in revenue for the fiscal quarter ending in April, and a surge in net income compared to the previous year. Despite concerns about supply chain constraints and export restrictions to China, analysts remain confident in Nvidia's growth potential.
Full articleSummary: Microsoft is moving towards AMD-based platforms for AI chips due to scarcity and high prices of NVIDIA's GPUs, introducing MI300X chip for cloud computing customers. Microsoft to showcase AMD's chips and Cobalt 100 processors at upcoming Build Developer Conference.
Full articleSummary: Simon Property Group had its price target increased by Scotiabank from $142.00 to $152.00, with an overall consensus rating of Moderate Buy and an average price target of $141.40. The company also increased its dividend and announced a share buyback program. Institutional investors and hedge funds have recently modified their holdings of the stock.
Full articleSummary: The US District Court ordered AstraZeneca to pay $107.5m to Pfizer for infringing patents related to the lung cancer drug Tagrisso. A separate trial is set for June 2024 to address AstraZeneca's remaining defenses, potentially overturning the current verdict. In a different case, the European Patent Office upheld Moderna's key patent in a dispute with Pfizer and BioNTech over the use of mRNA technology in Comirnaty vaccine.
Full articleSummary: Bristol-Myers Squibb's CC-97540 is under clinical development for the treatment of Primary Progressive Multiple Sclerosis (PPMS) and several other conditions, such as non-Hodgkin lymphoma and lupus. GlobalData provides insights into the drug's phase transition success rate and likelihood of approval compared to indication benchmarks.
Full articleSummary: Charles Schwab Investment Management Inc. increased its stake in AppLovin Co., several other hedge funds have also modified their holdings of the company. AppLovin reported earnings beating consensus estimates with strong revenue growth. Multiple analysts have issued buy ratings and raised price targets for AppLovin stock.
Full articleSummary: Charles Schwab Investment Management Inc. increased its stake in Hillenbrand, Inc. by 4.8% in the 4th quarter, owning 868,965 shares worth approximately $41,580,000. Several other institutional investors also added to their positions in the company. CEO and CFO made insider purchases recently. Hillenbrand stock was trading up 1.1% and the company reported higher-than-expected earnings results for the quarter ending April 30th.
Full articleSummary: Wall Street bets on stellar quarterly results from Nvidia
Full articleSummary: ExxonMobil and NBA Africa launch a new Jr. NBA league in Luanda, Angola, in collaboration with PanAfricare to reach 10,000 youth participants through basketball clinics, competitions, and STEM sessions. The league will feature all-girls basketball clinics as well to promote girls' participation in sports and leadership roles.
Full articleSummary: Berkshire Hathaway's 13F filing revealed a $7.1 billion investment in Chubb, a Swiss-based insurer, and also showcased Warren Buffett's team's consistent net-selling activity for six consecutive quarters.
Full articleSummary: The dollar was steady as investors awaited further clues on U.S. interest rate path, with Fed officials showing caution despite signs of cooling inflation. Various Fed speakers are expected to speak, with markets awaiting Fed meeting minutes later in the week.
Full articleSummary: IBM was close to taking over from Fujitsu as the Post Office's core system provider, but the complexities of the project led to a u-turn and the Post Office went back to Fujitsu for help. The Horizon retail and accounting system is at the center of a UK scandal. The Post Office is still trying to replace the Horizon system and Fujitsu contract with an in-house built platform named New Branch IT (NBIT).
Full articleSummary: Inflation data shows relief with slowing CPI, bond prices rise as equities follow, technology sector gains ahead of Nvidia results with stocks like NVDA, MSFT, AAPL leading the way, meme stocks like GME make a resurgence in the market.
Full articleSummary: The Charles Schwab Corporation (SCHW) closed slightly lower compared to broader market indices. Analysts are expecting a decline in earnings and revenue for the company's next report. Recent estimate revisions are reflecting analyst optimism. The company has a Zacks Rank of #3 (Hold) and valuation metrics suggest a premium compared to industry averages.
Full articleSummary: Berkshire Hathaway's CEO Warren Buffett revealed to have acquired a 6.4% stake in Chubb and been increasing activity in equities selling, having net equity sales totaling over $56 billion in the past 18 months. This may signal a lack of current value on Wall Street.
Full articleSummary: Yardeni Research's chief investment strategist sees potential for a 50% rise in the Dow Jones Industrial Average to 60,000 by 2030 and a rise in the S&P 500 to 8,000, fueled by strong earnings growth and optimistic outlook.
Full articleSummary: Amgen settled the BPCIA complaint against Sandoz regarding denosumab biosimilars, with Sandoz being enjoined from selling the products until 2025. Celltrion also submitted an application for a denosumab biosimilar in 2023.
Full article